Thioperamide

Thioperamide
Clinical data
ATC code	none;
Identifiers
	IUPAC name N-Cyclohexyl-4-(1H-imidazol-4-yl)piperidine-1-carbothioamide;
CAS Number	106243-16-7 ;
PubChem CID	3035905;
IUPHAR/BPS	1267;
ChemSpider	2300031 ;
ChEMBL	ChEMBL260374 ;
CompTox Dashboard (EPA)	DTXSID50147555 ;
Chemical and physical data
Formula	C15H24N4S
Molar mass	292.44 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES S=C(N2CCC(c1cncn1)CC2)NC3CCCCC3;
	InChI InChI=1S/C15H24N4S/c20-15(18-13-4-2-1-3-5-13)19-8-6-12(7-9-19)14-10-16-11-17-14/h10-13H,1-9H2,(H,16,17)(H,18,20) ; Key:QKDDJDBFONZGBW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Thioperamide is a potent HRH₄ antagonist and selective HRH₃ antagonist capable of crossing the blood–brain barrier.^[1] It was used by Jean-Charles Schwartz in his early experiments regarding the H₃ receptor.^[2] Thioperamide was found to be an antagonist of histamine autoreceptors, which negatively regulate the release of histamine, and enhances the activity of histaminergic neurons by blocking autoreceptors, leading to greater release of histamine.

References

^ "IUPHAR Database | Ligand Summary | thioperamide".
^ Schwartz, Jean-Charles. The histamine H3 receptor: from discovery to clinical trials with pitolisant. BPJ 2011 May [1]

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[urlIUPHAR_Database_|_Ligand_Summary_|_thioperamide-1] "IUPHAR Database | Ligand Summary | thioperamide".

[2] Schwartz, Jean-Charles. The histamine H3 receptor: from discovery to clinical trials with pitolisant. BPJ 2011 May [1]

[1]

[2]

See also

References